Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Methodological concerns limiting the detection of treatment effects in the OSAN trial of blue-blocking glasses for mania
Tone Elise Gjøtterud Henriksen; Jörg Assmus; Barbara Barbini; Francesco Benedetti; Jeanette Solheimslid Bjørke; Ole Bernt Fasmer; Pierre Alexis Geoffroy; John Gottlieb; Håvard Kallestad; James Phelps; Ieva Ratke; Peter F.J. Schulte; Silje SkredeShow moreShow less
1. Department of Mental Health Care, Valen Hospital, Fonna Hospital Trust, Valen, Norway; 2. Department of Research and Innovation, Fonna Hospital Trust, Haugesund, Norway; 3. Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway; 4. Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy; 5. School of Medicine, Università Vita-Salute San Raffaele, Milan, Italy; 6. Psychiatric Division, Stavanger University Hospital, Stavanger, Norway; 7. Division of Psychiatry, Haukeland University Hospital, Bergen, Norway; 8. Department of Clinical Medicine, University of Bergen, Bergen, Norway; 9. Mohn Research Center for Psychotic Disorders, Bergen, Norway; 10. Département de psychiatrie et d’addictologie, GHU Paris Nord, DMU Neurosciences NeuroDiderot, AP-HP, Université Paris Cité, Paris, France; 11. Centre ChronoS, GHU Paris - Psychiatrie & Neurosciences, Paris, France; 12. Institute for Cellular and Integrative Neurosciences, CNRS UPR 3212 & Strasbourg University, Strasbourg, France; 13. Chicago Psychiatry Associates, Chicago, USA; 14. Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway; 15. Department of Mental Health Care, St. Olavs Hospital, Trondheim, Norway; 16. DepressionEducation.org, Corvallis, USA; 17. Mental Health Services Noord-Holland‐Noord, Alkmaar, Netherlands; 18. Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway; 19. Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, NorwayShow moreShow less
Trajectories of psychotropic drug use patterns in psychiatric inpatients with acute depressive episodes of bipolar disorder: results from a pharmacovigilance program in German-speaking countries from 2007 to 2024
Johanna Seifert; Susanne Stübner; Dominik Dabbert; Waldemar Greil; Hannah B. Maier; Renate Grohmann; Sermin TotoShow moreShow less
1. Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany; 2. Department of Psychiatry and Psychotherapy, University Hospital LMU, Munich, Germany; 3. Department of Forensic Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, Rheinau, Switzerland; 4. Department of Forensic Psychiatry and Psychotherapy, Klinik Bremen-Ost, Bremen, Germany; 5. Psychiatric Private Hospital, Zurich, Switzerland; 6. Department of Psychiatry and Psychotherapy, School of Medicine & Health Sciences, Carl Von Ossietzky University of Oldenburg, Oldenburg, GermanyShow moreShow less
Electronic health record–observed lithium persistence after within-service initiation in bipolar disorder: an incident-initiator cohort study from a multinational tertiary psychiatric service in the United Arab Emirates
Syed Ali Bokhari; Muhanad Elnoor; Mohamed A. Alnor; Syed Fahad JavaidShow moreShow less
1. Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, United Arab Emirates; 2. Department of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 3. Department of Psychiatry, Faculty of Medicine, University of Khartoum, Khartoum, Sudan; 4. Department of Psychiatry, Al Ain Hospital, SEHA, Al Ain, United Arab EmiratesShow moreShow less
Machine learning for early detection and mood shift prediction in bipolar disorder: a systematic review
Shihshuan Fang; Shenghan ChenShow moreShow less
1. Department of Geriatrics, Landseed International Hospital, Taoyuan City, Taiwan; 2. Department of Neurology, Landseed International Hospital, Taoyuan City, TaiwanShow moreShow less
Objective sleep parameters and cognitive performance in euthymic bipolar disorder: a cross-sectional 21-day actigraphy study
Candice Libourel; Mathilde Charron; Victoire Martinot; Mathilde Carminati; Bruno Etain; Vincent HennionShow moreShow less
1. Optimisation Thérapeutique en Neuropharmacologie, UMR-S 1144, Université Paris Cité, Inserm, Paris, France; 2. Université de Bordeaux, Bordeaux, France; 3. Département de Psychiatrie et de Médecine Addictologique, Hôpitaux Lariboisière- Fernand Widal, GHU-APHP Nord, Paris, France; 4. Centre Expert Troubles Bipolaires et Dépressions Résistantes, Hôpital Fernand-Widal, Paris, FranceShow moreShow less
A preliminary cross-sectional study of bipolarity and primary pharmacotherapy in long-term stable patients with major depressive disorder
Taku Maruki; Takashi Tsuboi; Hitoshi Maeshima; Yasuyuki Matsumoto; Teruo Tada; Koichiro WatanabeShow moreShow less
1. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan; 2. Department of Psychiatry, Shizuoka hospital, Juntendo University School of Medicine, Shizuoka, JapanShow moreShow less
FAQ
How long does International Journal of Bipolar Disorders take to review a manuscript?
As of 2026-11-18, CrushSCI has 14 complete review records for International Journal of Bipolar Disorders. The fastest paper went from submission to acceptance in 50 days (Objective sleep parameters and cognitive performance in euthymic bipolar disorder: a cross-sectional 21-day actigraphy study, received 2026-04-16, accepted 2026-06-05); the slowest took 242 days. The average is 120.8 days and the median is 96.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
